Search

everythinglearnresearchcommunity

for

Search:↓

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Hair thickness differences help diagnose hair loss severity.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Trichoscopy is a useful tool for diagnosing hair and scalp issues, but doctors must be careful to avoid mistakes.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

Scalp microneedling may improve hair density and thickness for various alopecia types.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Consider benefits and risks of new alopecia treatments for safety.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

FGF-2&D/P nanoparticles can help treat hair loss.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.